BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 30526772)

  • 61. Anti-TNF-α treatment modulates SASP and SASP-related microRNAs in endothelial cells and in circulating angiogenic cells.
    Prattichizzo F; Giuliani A; Recchioni R; Bonafè M; Marcheselli F; De Carolis S; Campanati A; Giuliodori K; Rippo MR; Brugè F; Tiano L; Micucci C; Ceriello A; Offidani A; Procopio AD; Olivieri F
    Oncotarget; 2016 Mar; 7(11):11945-58. PubMed ID: 26943583
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Adamantinomatous craniopharyngioma as a model to understand paracrine and senescence-induced tumourigenesis.
    Gonzalez-Meljem JM; Martinez-Barbera JP
    Cell Mol Life Sci; 2021 May; 78(10):4521-4544. PubMed ID: 34019103
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The emerging role of cellular senescence in renal diseases.
    Zhou B; Wan Y; Chen R; Zhang C; Li X; Meng F; Glaser S; Wu N; Zhou T; Li S; Francis H; Alpini G; Zou P
    J Cell Mol Med; 2020 Feb; 24(3):2087-2097. PubMed ID: 31916698
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Senescence and apoptosis: dueling or complementary cell fates?
    Childs BG; Baker DJ; Kirkland JL; Campisi J; van Deursen JM
    EMBO Rep; 2014 Nov; 15(11):1139-53. PubMed ID: 25312810
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Targeting senescent cells: approaches, opportunities, challenges.
    von Kobbe C
    Aging (Albany NY); 2019 Nov; 11(24):12844-12861. PubMed ID: 31789602
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Myeloid-derived suppressor cells (MDSC): an important partner in cellular/tissue senescence.
    Salminen A; Kauppinen A; Kaarniranta K
    Biogerontology; 2018 Oct; 19(5):325-339. PubMed ID: 29959657
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Autophagy facilitates oncogene-induced senescence.
    Narita M; Young AR; Narita M
    Autophagy; 2009 Oct; 5(7):1046-7. PubMed ID: 19652542
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A tale of the good and bad: Cell senescence in bone homeostasis and disease.
    Liu X; Wan M
    Int Rev Cell Mol Biol; 2019; 346():97-128. PubMed ID: 31122396
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cancer Response to Therapy-Induced Senescence: A Matter of Dose and Timing.
    Mongiardi MP; Pellegrini M; Pallini R; Levi A; Falchetti ML
    Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33513872
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Senescent fibroblasts drive ageing pigmentation: ​A potential therapeutic target for senile lentigo.
    Yoon JE; Kim Y; Kwon S; Kim M; Kim YH; Kim JH; Park TJ; Kang HY
    Theranostics; 2018; 8(17):4620-4632. PubMed ID: 30279727
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Senescence-associated extracellular vesicle release plays a role in senescence-associated secretory phenotype (SASP) in age-associated diseases.
    Tanaka Y; Takahashi A
    J Biochem; 2021 Mar; 169(2):147-153. PubMed ID: 33002139
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line.
    Ortiz-Montero P; Londoño-Vallejo A; Vernot JP
    Cell Commun Signal; 2017 May; 15(1):17. PubMed ID: 28472950
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer.
    Mori JO; Elhussin I; Brennen WN; Graham MK; Lotan TL; Yates CC; De Marzo AM; Denmeade SR; Yegnasubramanian S; Nelson WG; Denis GV; Platz EA; Meeker AK; Heaphy CM
    Nat Rev Urol; 2024 May; 21(5):258-273. PubMed ID: 37907729
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Impact of Senescent Cell Subtypes on Tissue Dysfunction and Repair: Importance and Research Questions.
    Tripathi U; Misra A; Tchkonia T; Kirkland JL
    Mech Ageing Dev; 2021 Sep; 198():111548. PubMed ID: 34352325
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Senescent fibroblasts in melanoma initiation and progression: an integrated theoretical, experimental, and clinical approach.
    Kim E; Rebecca V; Fedorenko IV; Messina JL; Mathew R; Maria-Engler SS; Basanta D; Smalley KS; Anderson AR
    Cancer Res; 2013 Dec; 73(23):6874-85. PubMed ID: 24080279
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Non-Cell-Autonomous Regulation of Cellular Senescence in Cancer.
    Di Mitri D; Alimonti A
    Trends Cell Biol; 2016 Mar; 26(3):215-226. PubMed ID: 26564316
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Targeting Senescent Cells in Fibrosis: Pathology, Paradox, and Practical Considerations.
    Schafer MJ; Haak AJ; Tschumperlin DJ; LeBrasseur NK
    Curr Rheumatol Rep; 2018 Jan; 20(1):3. PubMed ID: 29374361
    [TBL] [Abstract][Full Text] [Related]  

  • 78. From Development to Aging: The Path to Cellular Senescence.
    Sacco A; Belloni L; Latella L
    Antioxid Redox Signal; 2021 Feb; 34(4):294-307. PubMed ID: 32228062
    [No Abstract]   [Full Text] [Related]  

  • 79. Cellular senescence in cancer: from mechanisms to detection.
    Ou HL; Hoffmann R; González-López C; Doherty GJ; Korkola JE; Muñoz-Espín D
    Mol Oncol; 2021 Oct; 15(10):2634-2671. PubMed ID: 32981205
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Ginsenoside F1 suppresses astrocytic senescence-associated secretory phenotype.
    Hou J; Cui C; Kim S; Sung C; Choi C
    Chem Biol Interact; 2018 Mar; 283():75-83. PubMed ID: 29412148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.